Streetbeat News

Analyst Ratings

CATY

Keefe, Bruyette & Woods analyst Christopher Mcgratty has maintained a Market Perform rating on Cathay General (NASDAQ:CATY) and lowered the price target from $46 to $41.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:56 pm

CDTX

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Cidara Therapeutics (NASDAQ:CDTX), indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:54 pm

BSRR

Keefe, Bruyette & Woods analyst Wood Lay maintains a Market Perform rating on Sierra (NASDAQ:BSRR) and lowers the price target from $24 to $23.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:53 pm

BOH

Keefe, Bruyette & Woods analyst Kelly Motta maintains an Underperform rating on Bank of Hawaii (NYSE:BOH) and raises the price target from $55 to $58.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:50 pm

DDOG

Wells Fargo analyst Andrew Nowinski upgrades Datadog (DDOG) from Equal-Weight to Overweight and increases the price target from $130 to $150.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:49 pm

AAPL

BofA Securities analyst Wamsi Mohan has reiterated a Buy rating for Apple Inc. (AAPL) with a price objective of $225, citing four key catalysts: capital return re-upping, Gen AI announcements, iPhone 16 launch, and gross profit growth re-acceleration. Mohan highlights a strong iPhone upgrade cycle in FY 2025, driven by Gen AI demand, and anticipates robust Services revenue growth and higher margins from internal silicon use. A new buyback authorization is expected in the F2Q earnings call. Apple's stock was trading at $167.13 at the time of publication.

Portfolio Pulse from Surbhi Jain

April 23, 2024 | 12:49 pm

ABEO

Cantor Fitzgerald analyst Kristen Kluska reiterated an Overweight rating on Abeona Therapeutics (NASDAQ:ABEO) and maintained a $36 price target.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:47 pm

BCBP

Keefe, Bruyette & Woods analyst Christopher O'Connell maintains a Market Perform rating on BCB Bancorp (NASDAQ:BCBP) and lowers the price target from $14 to $12.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:44 pm

AMZN

CHD

CHWY

INTC

MAR

PI

RBLX

SSD

VERX

ZION

Top Wall Street analysts have updated their price targets and ratings for several US-listed companies, including notable changes for Impinj, Intel, Chewy, Vertex, Marriott International, Amazon, Simpson Manufacturing, Church & Dwight, Zions Bancorporation, and Roblox. These adjustments reflect the analysts' latest views on these stocks, with implications for their short-term price movements.

Portfolio Pulse from Avi Kapoor

April 23, 2024 | 12:37 pm

NBIX

Needham analyst Ami Fadia reiterates a Hold rating on Neurocrine Biosciences (NASDAQ:NBIX), indicating no change in the investment firm's stance on the stock.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:37 pm